175 related articles for article (PubMed ID: 35622318)
21. BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan.
Chen YL; Su IJ; Cheng HY; Chang KC; Lu CC; Chow NH; Ho CL; Huang W
Leuk Lymphoma; 2010 Apr; 51(4):650-5. PubMed ID: 20233058
[TBL] [Abstract][Full Text] [Related]
22. Improvements to B cell clonality analysis using PCR amplification of immunoglobulin light chain genes.
Diss TC; Liu HX; Du MQ; Isaacson PG
Mol Pathol; 2002 Apr; 55(2):98-101. PubMed ID: 11950958
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction.
Lukowsky A; Marchwat M; Sterry W; Gellrich S
Leuk Lymphoma; 2006 Mar; 47(3):487-93. PubMed ID: 16396773
[TBL] [Abstract][Full Text] [Related]
24. Improved clonality detection in B-cell lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH rearrangement: A paraffin-embedded tissue study.
Sakamoto Y; Masaki A; Aoyama S; Han S; Saida K; Fujii K; Takino H; Murase T; Iida S; Inagaki H
Pathol Int; 2017 Sep; 67(9):453-460. PubMed ID: 28868745
[TBL] [Abstract][Full Text] [Related]
25. Detection of immunoglobulin IGH gene rearrangements on formalin-fixed, paraffin embedded tissue in lymphoid malignancies.
Moharrami G; Ghorbian S; Seifi M; Estiar MA; Fakhrjoo A; Sakhinia M; Sakhinia E
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(4):43-7. PubMed ID: 25481017
[TBL] [Abstract][Full Text] [Related]
26. Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue study.
Han S; Masaki A; Sakamoto Y; Takino H; Murase T; Iida S; Inagaki H
Pathol Int; 2018 May; 68(5):287-293. PubMed ID: 29575591
[TBL] [Abstract][Full Text] [Related]
27. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
[TBL] [Abstract][Full Text] [Related]
28. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.
Stewart JP; Gazdova J; Darzentas N; Wren D; Proszek P; Fazio G; Songia S; Alcoceba M; Sarasquete ME; Villarese P; van der Klift MY; Heezen KC; McCafferty N; Pal K; Catherwood M; Kim CS; Srivastava S; Kroeze LI; Hodges E; Stamatopoulos K; Klapper W; Genuardi E; Ferrero S; van den Brand M; Cazzaniga G; Davi F; Sutton LA; Garcia-Sanz R; Groenen PJTA; Macintyre EA; Brüggemann M; Pott C; Langerak AW; Gonzalez D;
Blood Adv; 2021 Aug; 5(16):3188-3198. PubMed ID: 34424321
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of IGK and IGL molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma.
Ghorbian S; Jahanzad I; Javadi GR; Sakhinia E
Hematology; 2016 Apr; 21(3):133-7. PubMed ID: 26183240
[TBL] [Abstract][Full Text] [Related]
30. Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases.
Krafft AE; Taubenberger JK; Sheng ZM; Bijwaard KE; Abbondanzo SL; Aguilera NS; Lichy JH
Mol Diagn; 1999 Jun; 4(2):119-33. PubMed ID: 10462627
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of BIOMED-2 assays for detection of clonal Ig gene rearrangements in mature B-cell lymphomas].
Zhang J; Wu YH; Kong HY; Zhou XG; Jin HS; Wu XM; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):739-44. PubMed ID: 20079012
[TBL] [Abstract][Full Text] [Related]
33. B-cell clonality determination using an immunoglobulin kappa light chain polymerase chain reaction method.
Pai RK; Chakerian AE; Binder JM; Amin M; Viswanatha DS
J Mol Diagn; 2005 May; 7(2):300-7. PubMed ID: 15858155
[TBL] [Abstract][Full Text] [Related]
34. A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology.
Liu H; Bench AJ; Bacon CM; Payne K; Huang Y; Scott MA; Erber WN; Grant JW; Du MQ
Br J Haematol; 2007 Jul; 138(1):31-43. PubMed ID: 17555445
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements.
Ghorbian S
Ann Diagn Pathol; 2017 Aug; 29():28-31. PubMed ID: 28807338
[TBL] [Abstract][Full Text] [Related]
36. Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol.
Sandberg Y; Heule F; Lam K; Lugtenburg PJ; Wolvers-Tettero IL; van Dongen JJ; Langerak AW
Haematologica; 2003 Jun; 88(6):659-70. PubMed ID: 12801842
[TBL] [Abstract][Full Text] [Related]
37. Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients.
Ha J; Lee H; Shin S; Cho H; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
J Mol Diagn; 2022 Jan; 24(1):48-56. PubMed ID: 34656761
[TBL] [Abstract][Full Text] [Related]
38. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.
Langerak AW; Groenen PJ; Brüggemann M; Beldjord K; Bellan C; Bonello L; Boone E; Carter GI; Catherwood M; Davi F; Delfau-Larue MH; Diss T; Evans PA; Gameiro P; Garcia Sanz R; Gonzalez D; Grand D; Håkansson A; Hummel M; Liu H; Lombardia L; Macintyre EA; Milner BJ; Montes-Moreno S; Schuuring E; Spaargaren M; Hodges E; van Dongen JJ
Leukemia; 2012 Oct; 26(10):2159-71. PubMed ID: 22918122
[TBL] [Abstract][Full Text] [Related]
39. Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas.
Lassmann S; Gerlach UV; Technau-Ihling K; Werner M; Fisch P
J Mol Diagn; 2005 Nov; 7(5):582-91. PubMed ID: 16258156
[TBL] [Abstract][Full Text] [Related]
40. [PCR definition of B-cell clonality: which electrophoretic method is better].
Sidorova IuV; Nikitin EA; Ryzhikova NV; Sudarikov AB
Ter Arkh; 2008; 80(7):43-7. PubMed ID: 18763594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
